DE69935071D1 - Mutein von humanem Thrombopoietin - Google Patents

Mutein von humanem Thrombopoietin

Info

Publication number
DE69935071D1
DE69935071D1 DE69935071T DE69935071T DE69935071D1 DE 69935071 D1 DE69935071 D1 DE 69935071D1 DE 69935071 T DE69935071 T DE 69935071T DE 69935071 T DE69935071 T DE 69935071T DE 69935071 D1 DE69935071 D1 DE 69935071D1
Authority
DE
Germany
Prior art keywords
htpo
derivatives
novel
human thrombopoietin
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69935071T
Other languages
English (en)
Other versions
DE69935071T2 (de
Inventor
Joo Young Chung
Sang Kyu Park
Sang Myoung Ju
Hyea Kyung Ahn
Seung Wook Lim
Woo Ik Chang
Seung Kook Park
Yeo Wook Koh
Ji Soo Park
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daewoong Pharmaceutical Co Ltd
Original Assignee
Daewoong Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daewoong Pharmaceutical Co Ltd filed Critical Daewoong Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69935071D1 publication Critical patent/DE69935071D1/de
Publication of DE69935071T2 publication Critical patent/DE69935071T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/524—Thrombopoietin, i.e. C-MPL ligand
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Amplifiers (AREA)
  • Fittings On The Vehicle Exterior For Carrying Loads, And Devices For Holding Or Mounting Articles (AREA)
DE69935071T 1998-06-30 1999-06-30 Mutein von humanem Thrombopoietin Expired - Fee Related DE69935071T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR9825935 1998-06-30
KR19980025935 1998-06-30
KR1019990025143A KR20000006549A (ko) 1998-06-30 1999-06-29 생체내혈소판증식효능이향상된신규한트롬보포이에틴유도체
KR9925143 1999-06-29
PCT/KR1999/000347 WO2000000612A1 (en) 1998-06-30 1999-06-30 A novel human thrombopoietin mutein

Publications (2)

Publication Number Publication Date
DE69935071D1 true DE69935071D1 (de) 2007-03-22
DE69935071T2 DE69935071T2 (de) 2007-07-26

Family

ID=26633859

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69935071T Expired - Fee Related DE69935071T2 (de) 1998-06-30 1999-06-30 Mutein von humanem Thrombopoietin

Country Status (11)

Country Link
EP (1) EP1092029B1 (de)
JP (2) JP3646927B2 (de)
KR (2) KR20000006549A (de)
CN (1) CN1145694C (de)
AT (1) ATE353340T1 (de)
AU (1) AU4655899A (de)
BR (1) BR9911686A (de)
CA (1) CA2332126C (de)
DE (1) DE69935071T2 (de)
ID (1) ID27396A (de)
WO (1) WO2000000612A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005033135A1 (en) 2003-10-09 2005-04-14 Daewoong Co., Ltd. Process for purifying human thrombopoietin with high content of sialic acid
JP2009545309A (ja) * 2006-08-04 2009-12-24 ダブリン シティ ユニバーシティ 組換え型生物学的製剤を製造する方法
WO2010085086A2 (ko) 2009-01-20 2010-07-29 한올바이오파마 주식회사 변형된 인간 트롬보포이에틴 폴리펩타이드 절편 및 그의 제조방법
KR101594845B1 (ko) * 2014-04-29 2016-02-17 주식회사 청하 디플렉터 워터필름 수지 조성물
KR20160005968A (ko) 2014-07-08 2016-01-18 한화테크윈 주식회사 감시 카메라의 조립 구조

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2285446B (en) * 1994-01-03 1999-07-28 Genentech Inc Thrombopoietin
EP0668352A1 (de) * 1994-02-14 1995-08-23 Kirin Brewery Company, Ltd. Protein mit TPO-Aktivität
WO1996017062A1 (en) * 1994-11-30 1996-06-06 Zymogenetics, Inc. Low molecular weight thrombopoietin
AU691410B2 (en) * 1995-02-15 1998-05-14 Amgen, Inc. MPL ligand analogs

Also Published As

Publication number Publication date
DE69935071T2 (de) 2007-07-26
KR100331977B1 (ko) 2002-04-10
CA2332126C (en) 2008-09-23
ID27396A (id) 2001-04-05
JP3646927B2 (ja) 2005-05-11
AU4655899A (en) 2000-01-17
JP2002519031A (ja) 2002-07-02
ATE353340T1 (de) 2007-02-15
BR9911686A (pt) 2001-03-20
EP1092029A1 (de) 2001-04-18
WO2000000612A1 (en) 2000-01-06
EP1092029B1 (de) 2007-02-07
CA2332126A1 (en) 2000-01-06
CN1145694C (zh) 2004-04-14
CN1306573A (zh) 2001-08-01
KR20010078744A (ko) 2001-08-21
JP2005046156A (ja) 2005-02-24
KR20000006549A (ko) 2000-01-25

Similar Documents

Publication Publication Date Title
DE60330181D1 (de) Actriib-fusionspolypeptide und verwendungen dafür
MXPA03006771A (es) Anticuerpos modificados y metodos de uso.
DE69503849D1 (de) Zusammensetzungen und Verfahren zur Anregung des Wachstums und der Differenzierung von Megakaryozyten
DE60039055D1 (de) Mittel und methoden zur beeinflussung pflanzlicher blüheigenschaften
TR199802789T2 (xx) Eksendin analoglar� bunlar�n �retimi i�in y�ntemler ve bunlar� i�eren farmas�tik m�stahzarlar.
IL144446A0 (en) Plasma protein matrices and methods for their preparation
WO2001068811A3 (de) Verfahren zur in vitro-herstellung von dreidimensionalem, vitalem knorpel- oder knochengewebe und dessen verwendung als transplantationsmaterial
HK1085140A1 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
WO1998049300A3 (en) Truncated vegf-related proteins
DE69631544D1 (de) Fettleibigkeitsprotein (ob) zur erhögung der mageren körpermasse
AR041061A1 (es) Uso de la eritropoyetina en pacientes con diabetes
CN100469790C (zh) 重组体bmp-2的生产
ATE190352T1 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
PT851926E (pt) Variantes do interferao-gama (rhu-ifn-gama) recombinante humano com estabilidade termica melhorada
HUP0500637A2 (hu) Neublasztin polimer konjugátumai és alkalmazási eljárásai
DE69935071D1 (de) Mutein von humanem Thrombopoietin
PL346143A1 (en) Tan-1057 derivatives
WO1996015758A3 (en) Methods for stimulating erythropoiesis using thrombopoietin
WO1997015668A3 (en) Methods and compositions comprising glut-2 and glut-2 chimeras
EA200400174A1 (ru) Трансгенные растения, экспрессирующие кобаламинсвязывающие белки
MXPA02012378A (es) Secuencias de nucleotidos y aminoacidos de factores de oocito para alterar el crecimiento folicular ovarico in vivo in vitro.
ES2082212T3 (es) Nuevos inhibidores de alfa-glucosidasa.
Asgary et al. The effect of flavonoids on the prevention of hemoglobin glycosylation
KR970015742A (ko) 택솔유사 단백질(talp) 및 그의 제조방법

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee